Bloom Energy Corporation (BE)
Key Takeaways:
Valuation Metrics
Profitability is being valued at a premium: trailing P/E 377.41 and forward P/E 55.94 indicate the market expects a turnaround/continued improvement but current earnings power is still low relative to price.
Cash-flow/earnings discounting looks mixed: P/FCF 203.33 is very high, implying either weak/volatile free cash flow or expectations of future cash generation that are not yet realized.
Sales-multiple indicates “growth/tech-like” pricing: P/S 26.20 and EV/Sales 30.58 are extremely elevated versus typical value investing thresholds; this generally requires sustained high growth and margin expansion.
Balance-sheet valuation also looks expensive: P/B 50.41 suggests the equity base is relatively small versus market value (and/or book value not capturing asset economics), making book-value-based value approaches less reliable here.
PEG is high: PEG 0.47 (below 1) would normally be favorable for growth-adjusted valuation, but given the very high P/E and P/FCF, PEG here may be distorted by earnings volatility/low denominator (and should be treated cautiously).
Earnings-multiple vs operating leverage: EV/EBITDA 130.05 reinforces that operating profits/EBITDA are still not strong enough today to justify price on conventional metrics.
Earnings & Profitability
Margins are currently strong-looking but still need sustainability: Gross Margin 85.14%, Oper. Margin 31.22%, Profit Margin 11.21%. High gross margin is consistent with differentiation, but the investment thesis should focus on whether operating margins can be sustained as scale increases.
RO metrics are elevated: ROA 2.08, ROE 6.00, ROIC 22.20%. The ROIC strength is the most constructive sign for value-growth blend investors, suggesting some value creation once capital is deployed.
Earnings growth acceleration: EPS (ttm) 0.68 with EPS this Y 0.68 and very large growth projections (see Growth section) suggests the market is pricing meaningful future ramp.
Quality/consistency signals from surprises: EPS/Sales Surpr. 39.01% implies earnings are coming in meaningfully different than expectations (direction not provided). If positive on average, it supports the turnaround narrative; if volatile, it increases risk.
Growth Analysis
Forecasts imply aggressive forward growth: EPS next Y 4.03 vs EPS (ttm) 0.68 indicates an implied uplift of roughly 5.9x, consistent with a “ramp” phase.
Medium-term growth expectation: EPS next 5Y 4.95 suggests sustained improvement rather than a one-off spike.
Recent trend is improving: EPS Y/Y TTM 255.11% and Sales Y/Y TTM 83.48% indicate strong momentum in both earnings and revenue.
Quarterly improvement: EPS Q/Q 119.05% and Sales Q/Q 20.18% suggest accelerating profitability even if quarterly sales growth is more moderate than EPS growth.
However, high multiples mean growth must not only be present but also relatively durable—any deceleration could cause multiple compression given the currently expensive valuation (P/S, P/B).
Financial Health
Liquidity is adequate: Quick Ratio 0.73 and Current Ratio 1.21. Quick ratio below 1 suggests some reliance on ongoing cash generation/working capital management.
Leverage is moderate-to-high relative to equity: Debt/Eq 1.74 and LT Debt/Eq 1.69. This can be manageable if operating cash flow scales, but it increases downside risk if growth slows.
Equity base appears small vs market value (also implied by P/B 50.41), so leverage metrics should be interpreted with caution; still, debt remains a key risk factor for a company priced for strong execution.
Profitability supports the balance-sheet story indirectly: operating margin and ROIC 22.20% suggest the business model can generate returns, which is crucial when leverage exists.
Ownership Structure
Insiders own a meaningful stake: Insider Own 5.97%, which can be a positive alignment signal (though insider trades data is ambiguous here: Insider Trans -1.79% is not directionally interpretable without more context).
Institutions appear heavily involved: Inst Own 85.14% with Inst Trans 2.08%. High institutional ownership often improves monitoring/liquidity but can also mean crowded positioning in a high-multiple name.
For both value and growth investors, the key implication is that the stock’s narrative is widely held; re-rating risk exists if forward assumptions are challenged.
Market Performance
Trend vs moving averages indicates weakness/mean reversion risk: Price 291.25 is below SMA20 276.98 slightly above/near, below SMA50 293.00 by a small margin, and above SMA200 218.77. Net: still above long-term trend but not strongly extended vs mid-term.
Recent performance is strongly positive over long windows: Perf 3Y 1988.84%, Perf 5Y 1379.59%, Perf 10Y 227.52% (very strong compounding), consistent with a high-expectation growth story.
But near-term is mixed: Perf Week -1.79% and Perf Month -4.32% show recent pullback/uncertainty.
Relative volume is elevated: Rel Volume 1.21, which often accompanies price-moving catalysts/positioning.
Momentum & Volatility
RSI is high: RSI (14) 70.89 suggests the stock has been relatively overbought in the short term (watch for pullback risk).
Volatility is elevated: Volatility 2.06 and ATR (14) 15.75 indicate large expected daily/near-term price movement; position sizing and entry discipline matter.
Beta is high: Beta 1.21, confirming above-market sensitivity—macro and risk-on sentiment will likely impact BE disproportionately.
52-week range context: 52W High 290.72 and 52W Low 15.75. Current price 291.25 is near the highs, implying limited upside before considering broader-market or fundamental updates.
Short interest is notable: Short Float 6.86%, Short Ratio 2.08, Short Interest 18.99M. This can create squeeze dynamics, but it doesn’t remove fundamental valuation risk.
Investment Recommendations
value Investor:
Given P/S 26.20, P/B 50.41, and very high P/E 377.41, BE does not screen as a classic value entry on current multiples. A value-style buy would require either (a) a large pullback toward far lower sales multiples or (b) substantial earnings/FCF expansion not yet reflected. With current data, a practical value trigger would be waiting for a meaningful de-risking event/decline—e.g., a pullback of roughly 25–40% from $291.25 (approx. $175–$220) paired with continued EPS growth and margin stability.
growth Investor:
For growth investors, the story is stronger: EPS Y/Y TTM 255.11%, EPS Q/Q 119.05%, and ROIC 22.20% support the ramp thesis. However, price is near highs and RSI is elevated (RSI ~70.9). A reasonable growth entry would be on weakness—e.g., 10–20% below $291.25 (approx. $235–$262) to improve forward expected returns while still participating in the growth trajectory.
Investment Summary
BE’s fundamentals show a strong ramp: EPS Y/Y +255%, sales Y/Y +83%, and ROIC 22% with solid margins. But valuation is extreme: P/S 26, P/B 50, and P/E 377, near 52W highs with RSI ~71—high downside if growth/margins wobble. Value investors: wait for a larger pullback (~$175–$220) or clear cash-flow improvement. Growth investors: consider buying dips (~$235–$262) with tight risk controls.
